Original Article
You have full text access to this OnlineOpen article
Risedronate reduces intracortical porosity in women with osteoporosis
Article first published online: 18 DEC 2009
DOI: 10.1359/jbmr.090711
Copyright © 2010 American Society for Bone and Mineral Research
Additional Information
How to Cite
Borah, B., Dufresne, T., Nurre, J., Phipps, R., Chmielewski, P., Wagner, L., Lundy, M., Bouxsein, M., Zebaze, R. and Seeman, E. (2010), Risedronate reduces intracortical porosity in women with osteoporosis. J Bone Miner Res, 25: 41–47. doi: 10.1359/jbmr.090711
Publication History
- Issue published online: 20 JAN 2010
- Article first published online: 18 DEC 2009
- Manuscript Accepted: 1 JUL 2009
- Manuscript Revised: 24 APR 2009
- Manuscript Received: 19 JAN 2009
References
- 1
- 2, , , , , . Rates of bone loss in the appendicular and axial skeletons of women: evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986; 77: 1487–1491.
- 3, , . et al. Population-based study of age and sex differences in bone volumetric density, size, geometry and structure at different skeletal sites. J Bone Miner Res. 2004; 19: 1945–1954Direct Link:
- 4, , . et al. A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res. 2008; 23: 205–214.Direct Link:
- 5, , , , , . Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int. 2001; 12: 989–995.
- 6, , , et al. The neglected role of intracortical remodeling in age-related bone loss. J Bone Miner Res. 2008; 23: S29.
- 7. Surface specific bone remodeling in health and disease. In: KleerekoperM, KraneS, eds. Clinical Disorders of Bone and Mineral Metabolism. New York: Mary Ann Liebert; 1989: 7–14.
- 8, , , , . Effect of ethnicity and age or menopause on the structure and geometry of iliac bone. J Bone Miner Res. 1996; 11: 1967–1975.
- 9, , , et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized, controlled trial. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA. 1999; 282: 1344–1352.
- 10, , , , . Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. Bone. 2002; 31: 620–625.
- 11, , , . Five years of treatment with risedronate and its effects on bone safety in women with postmenopausal osteoporosis. Calcif Tissue Int. 2004; 75: 469–476.
- 12, , . Inter-observer and intra-observer variation in bone histomorphometry. Calcif Tissue Int. 1986; 38: 67–70.
- 13, , , , , . Bone remodeling at the endocortical surface of the human femoral neck: a mechanism for regional cortical thinning in cases of hip fracture. J Bone Miner Res. 2003; 18: 1775–1780.Direct Link:
- 14, . Expansion of the medullary cavity at the expense of cortex in postmenopausal osteoporosis. Metab Bone Dis Relat Res. 1984; 5: 223–228.
- 15, , , et al. Distribution of intracortical porosity in human midfemoral cortex by age and gender. J Bone Miner Res. 2001; 16: 1308–1317.Direct Link:
- 16, . Computer and Robot Vision. Vol. 1 Reading, MA: Addison-Wesley; 1992.
- 17. The physiologic and clinical significance of bone histomorphometric data. In: ReckerRR, ed. Bone Histomorphometry: Techniques and Interpretation. Boca Raton, FL: CRC Press; 1983: 143–223.
- 18, . The microscopic structure of bone. In: Structure, Function, and Adaptation of Compact Bone. New York: Raven Press; 1989: 18–56.
- 19, , , , . Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone. 1993; 14: 681–691.
- 20, , . Osteon morphometry in females with femoral neck fractures. Clin Orthop Relat Res. 1992; 283: 178–186.
- 21. Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55: 273–286.Direct Link:
- 22, , , . Histomorphometric assessment of haversian canal and osteocyte lacunae in different-sized osteons in human rib. Anat Rec A Discov Mol Cell Evol Biol. 2003; 272: 520–525.Direct Link:
- 23, , , . Osteon cross-sectional size in the iliac crest: variation in normals and patients with osteoporosis, hyperparathyroidism, acromegaly, hypothyroidism and treated epilepsia. Acta Pathol Microbiol Immunol Scand [A]. 1982; 90: 339–344.
- 24, , , , , . A novel mechanism for induction of increased cortical porosity in cases of intracapsular hip fracture. Bone 2000; 27: 297–304.
- 25The Mathworks, Inc. Image Processing Toolbox for Use with Matlab: User's Guide. Natick, MA: Mathworks Inc.; 2004.
- 26. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: MarcusR, FeldmanD, KelseyJ, eds. Osteoporosis. San Diego: Academic Press; 1996: 315–339.
- 27, . Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment. J Cell Biochem. 2008; 103: 393–400.Direct Link:
- 28, , , . The influence of bone morphology on fracture toughness of the human femur and tibia. Bone. 1997; 21: 453–459.
- 29, . The effects of collagen fiber orientation, porosity, density, and mineralization on bovine cortical bone bending properties. J Biomech. 1993; 26: 1047–1054.
- 30, . The relative effects of collagen fiber orientation, porosity, density, and mineralization on bone strength. J Biomech. 1989; 22: 419–426.
- 31, . Stiffness of compact bone: effects of porosity and density. J Biomech. 1988; 21: 13–16.
- 32. Treatment of postmenopausal osteoporosis. Lancet. 2002; 359: 2018–2026.
- 33, , . Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res. 1978; 26: 13–17.
- 34
- 35, , , , , . Osteoclastic cortical erosion as a determinant of subperiosteal osteoblastic bone formation in the femoral neck's response to BMU imbalance: effects of stance-related loading and hip fracture. Osteoporos Int. 2005; 16: 1049–1056.
- 36, , . et al. Relation between age, femoral neck cortical stability, and hip fracture risk. Lancet 2005; 366: 129–135.

1523-4681/asset/olbannerleft.gif?v=1&s=d7e4c0e37904a489128d3a4e58ba94214db307a9)
1523-4681/asset/olbannerright.gif?v=1&s=854ee0e4d351ead9faaca8bfab3e50b1c7c9d03d)
